Highly parallel characterization of IgG Fc binding interactions

References

• Jefferis R, Pound J, Lund J, Goodall M. Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Review article. Ann Biol Clin (Paris) 1994; 52:57 - 65; PMID: 8210076
   PubMed Web of Science ®Google Scholar
• Jefferis R, Lund J, Pound JD. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 1998; 163:59 - 76; http://dx.doi.org/10.1111/j.1600-065X.1998.tb01188.x; PMID: 9700502
   PubMed Web of Science ®Google Scholar
• Bazin R, Lemieux R, Tremblay T, St-Amour I. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells. Br J Haematol 2004; 127:90 - 6; http://dx.doi.org/10.1111/j.1365-2141.2004.05105.x; PMID: 15384982
   PubMed Web of Science ®Google Scholar
• Lux A, Yu X, Scanlan CN, Nimmerjahn F. Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J Immunol 2013; 190:4315 - 23; http://dx.doi.org/10.4049/jimmunol.1200501; PMID: 23509345
   PubMed Web of Science ®Google Scholar
• Teeling JL, Jansen-Hendriks T, Kuijpers TW, de Haas M, van de Winkel JG, Hack CE, Bleeker WK. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 2001; 98:1095 - 9; http://dx.doi.org/10.1182/blood.V98.4.1095; PMID: 11493456
   PubMed Web of Science ®Google Scholar
• Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. MAbs 2012; 4:17 - 23; http://dx.doi.org/10.4161/mabs.4.1.18347; PMID: 22327427
   PubMed Web of Science ®Google Scholar
• Lazar GA, Dang W, Karki S, Vafa O, Peng JS, Hyun L, Chan C, Chung HS, Eivazi A, Yoder SC, et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci U S A 2006; 103:4005 - 10; http://dx.doi.org/10.1073/pnas.0508123103; PMID: 16537476
   PubMed Web of Science ®Google Scholar
• de Lange GG. Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes. Exp Clin Immunogenet 1989; 6:7 - 17; PMID: 2698222
   PubMedGoogle Scholar
• Kumpel BM, Wiener E, Urbaniak SJ, Bradley BA. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function. Br J Haematol 1989; 71:415 - 20; http://dx.doi.org/10.1111/j.1365-2141.1989.tb04300.x; PMID: 2539182
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Translating basic mechanisms of IgG effector activity into next generation cancer therapies. Cancer Immun 2012; 12:13; PMID: 22896758
   PubMedGoogle Scholar
• Jefferis R. Isotype and glycoform selection for antibody therapeutics. Arch Biochem Biophys 2012; 526:159 - 66; http://dx.doi.org/10.1016/j.abb.2012.03.021; PMID: 22465822
   PubMed Web of Science ®Google Scholar
• Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 2013; 123:2183 - 92; http://dx.doi.org/10.1172/JCI65708; PMID: 23563315
   PubMed Web of Science ®Google Scholar
• Hess C, Winkler A, Lorenz AK, Holecska V, Blanchard V, Eiglmeier S, Schoen AL, Bitterling J, Stoehr AD, Petzold D, et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J Clin Invest 2013; 123:3788 - 96; http://dx.doi.org/10.1172/JCI65938; PMID: 23979161
   PubMed Web of Science ®Google Scholar
• Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 2013; Forthcoming http://dx.doi.org/10.1136/annrheumdis-2013-203565; PMID: 24106048
   PubMed Web of Science ®Google Scholar
• Bondt A, Selman MH, Deelder AM, Hazes JM, Willemsen SP, Wuhrer M, Dolhain RJ. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res 2013; 12:4522 - 31; http://dx.doi.org/10.1021/pr400589m; PMID: 24016253
   PubMed Web of Science ®Google Scholar
• Ackerman ME, Alter G. Opportunities to exploit non-neutralizing HIV-specific antibody activity. Curr HIV Res 2013; 11:365 - 77; http://dx.doi.org/10.2174/1570162X113116660058; PMID: 24191934
   PubMed Web of Science ®Google Scholar
• Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity 1994; 1:303 - 15; http://dx.doi.org/10.1016/1074-7613(94)90082-5; PMID: 7889418
   PubMed Web of Science ®Google Scholar
• Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A 2008; 105:19571 - 8; http://dx.doi.org/10.1073/pnas.0810163105; PMID: 19036920
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Fuchs A, Colonna M. Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol 2012; 188:4741 - 5; http://dx.doi.org/10.4049/jimmunol.1102651; PMID: 22491254
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Gilfillan S, Colonna M. Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses. J Immunol 2010; 185:2960 - 7; http://dx.doi.org/10.4049/jimmunol.1001428; PMID: 20668221
   PubMed Web of Science ®Google Scholar
• Arnold JN, Dwek RA, Rudd PM, Sim RB. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 2006; 106:103 - 10; http://dx.doi.org/10.1016/j.imlet.2006.05.007; PMID: 16814399
   PubMed Web of Science ®Google Scholar
• Keeble AH, Khan Z, Forster A, James LC. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci U S A 2008; 105:6045 - 50; http://dx.doi.org/10.1073/pnas.0800159105; PMID: 18420815
   PubMed Web of Science ®Google Scholar
• Dong X, Storkus WJ, Salter RD. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J Immunol 1999; 163:5427 - 34; PMID: 10553068
   PubMed Web of Science ®Google Scholar
• Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D, et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med 2012; 18:1401 - 6; http://dx.doi.org/10.1038/nm.2862; PMID: 22922409
   PubMed Web of Science ®Google Scholar
• Lu J, Marjon KD, Mold C, Du Clos TW, Sun PD. Pentraxins and Fc receptors. Immunol Rev 2012; 250:230 - 8; http://dx.doi.org/10.1111/j.1600-065X.2012.01162.x; PMID: 23046133
   PubMed Web of Science ®Google Scholar
• Stemerding AM, Köhl J, Pandey MK, Kuipers A, Leusen JH, Boross P, Nederend M, Vidarsson G, Weersink AY, van de Winkel JG, et al. Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J Immunol 2013; 191:353 - 62; http://dx.doi.org/10.4049/jimmunol.1203243; PMID: 23740955
   PubMed Web of Science ®Google Scholar
• Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daëron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009; 113:3716 - 25; http://dx.doi.org/10.1182/blood-2008-09-179754; PMID: 19018092
   PubMed Web of Science ®Google Scholar
• Warncke M, Calzascia T, Coulot M, Balke N, Touil R, Kolbinger F, Heusser C. Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment. J Immunol 2012; 188:4405 - 11; http://dx.doi.org/10.4049/jimmunol.1200090; PMID: 22461693
   PubMed Web of Science ®Google Scholar
• Brüggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987; 166:1351 - 61; http://dx.doi.org/10.1084/jem.166.5.1351; PMID: 3500259
   PubMed Web of Science ®Google Scholar
• Wasyl Z, Luchter E, Bielański W Jr.. Determination of the effective radius of protein molecules by thin-layer gel filtration. Biochim Biophys Acta 1971; 243:11 - 8; http://dx.doi.org/10.1016/0005-2795(71)90031-6; PMID: 4107733
   PubMed Web of Science ®Google Scholar
• Moore GL, Chen H, Karki S, Lazar GA. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs 2010; 2:181 - 9; http://dx.doi.org/10.4161/mabs.2.2.11158; PMID: 20150767
   PubMed Web of Science ®Google Scholar
• Richards JO, Karki S, Lazar GA, Chen H, Dang W, Desjarlais JR. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol Cancer Ther 2008; 7:2517 - 27; http://dx.doi.org/10.1158/1535-7163.MCT-08-0201; PMID: 18723496
   PubMed Web of Science ®Google Scholar
• Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol 1989; 143:2595 - 601; PMID: 2507634
   PubMed Web of Science ®Google Scholar
• Pound JD, Lund J, Jefferis R. Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst. Mol Immunol 1993; 30:233 - 41; http://dx.doi.org/10.1016/0161-5890(93)90052-D; PMID: 8381917
   PubMed Web of Science ®Google Scholar
• Nesspor TC, Raju TS, Chin CN, Vafa O, Brezski RJ. Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1. J Mol Recognit 2012; 25:147 - 54; http://dx.doi.org/10.1002/jmr.2155; PMID: 22407978
   PubMed Web of Science ®Google Scholar
• Li Y, Tao SC, Bova GS, Liu AY, Chan DW, Zhu H, Zhang H. Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. Anal Chem 2011; 83:8509 - 16; http://dx.doi.org/10.1021/ac201452f; PMID: 21975078
   PubMed Web of Science ®Google Scholar
• Baruah K, Bowden TA, Krishna BA, Dwek RA, Crispin M, Scanlan CN. Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. J Mol Biol 2012; 420:1 - 7; http://dx.doi.org/10.1016/j.jmb.2012.04.002; PMID: 22484364
   PubMed Web of Science ®Google Scholar
• Bowden TA, Baruah K, Coles CH, Harvey DJ, Yu X, Song BD, Stuart DI, Aricescu AR, Scanlan CN, Jones EY, et al. Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J Am Chem Soc 2012; 134:17554 - 63; http://dx.doi.org/10.1021/ja306068g; PMID: 23025485
   PubMed Web of Science ®Google Scholar
• Shibata-Koyama M, Iida S, Misaka H, Mori K, Yano K, Shitara K, Satoh M. Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils. Exp Hematol 2009; 37:309 - 21; http://dx.doi.org/10.1016/j.exphem.2008.11.006; PMID: 19218011
   PubMed Web of Science ®Google Scholar
• Zhou Q, Shankara S, Roy A, Qiu H, Estes S, McVie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T. Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol Bioeng 2008; 99:652 - 65; http://dx.doi.org/10.1002/bit.21598; PMID: 17680659
   PubMed Web of Science ®Google Scholar
• McGreal EP, Rosas M, Brown GD, Zamze S, Wong SY, Gordon S, Martinez-Pomares L, Taylor PR. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006; 16:422 - 30; http://dx.doi.org/10.1093/glycob/cwj077; PMID: 16423983
   PubMed Web of Science ®Google Scholar
• Kogelberg H, Tolner B, Sharma SK, Lowdell MW, Qureshi U, Robson M, Hillyer T, Pedley RB, Vervecken W, Contreras R, et al. Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. Glycobiology 2007; 17:36 - 45; http://dx.doi.org/10.1093/glycob/cwl053; PMID: 17000699
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587 - 97; http://dx.doi.org/10.1016/S0092-8674(00)80694-7; PMID: 10721995
   PubMed Web of Science ®Google Scholar
• Van Patten SM, Hughes H, Huff MR, Piepenhagen PA, Waire J, Qiu H, Ganesa C, Reczek D, Ward PV, Kutzko JP, et al. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. Glycobiology 2007; 17:467 - 78; http://dx.doi.org/10.1093/glycob/cwm008; PMID: 17251309
   PubMed Web of Science ®Google Scholar
• Franco A, Damdinsuren B, Ise T, Dement-Brown J, Li H, Nagata S, Tolnay M. Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J Immunol 2013; 190:5739 - 46; http://dx.doi.org/10.4049/jimmunol.1202860; PMID: 23616577
   PubMed Web of Science ®Google Scholar
• Yu X, Vasiljevic S, Mitchell DA, Crispin M, Scanlan CN. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J Mol Biol 2013; 425:1253 - 8; http://dx.doi.org/10.1016/j.jmb.2013.02.006; PMID: 23416198
   PubMed Web of Science ®Google Scholar
• Käsermann F, Boerema DJ, Rüegsegger M, Hofmann A, Wymann S, Zuercher AW, Miescher S. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS One 2012; 7:e37243; http://dx.doi.org/10.1371/journal.pone.0037243; PMID: 22675478
   PubMed Web of Science ®Google Scholar
• Bayry J, Bansal K, Kazatchkine MD, Kaveri SV. DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells. Proc Natl Acad Sci U S A 2009; 106:E24 - , author reply E25; http://dx.doi.org/10.1073/pnas.0900016106; PMID: 19237553
   PubMed Web of Science ®Google Scholar
• Crispin M, Yu X, Bowden TA. Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci U S A 2013; 110:E3544 - 6; http://dx.doi.org/10.1073/pnas.1310657110; PMID: 23929778
   PubMedGoogle Scholar
• Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci U S A 2013; 110:9868 - 72; http://dx.doi.org/10.1073/pnas.1307864110; PMID: 23697368
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Analyzing antibody-Fc-receptor interactions. Methods Mol Biol 2008; 415:151 - 62; PMID: 18370153
   PubMedGoogle Scholar
• Barouch DH, Yang ZY, Kong WP, Korioth-Schmitz B, Sumida SM, Truitt DM, Kishko MG, Arthur JC, Miura A, Mascola JR, et al. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol 2005; 79:8828 - 34; http://dx.doi.org/10.1128/JVI.79.14.8828-8834.2005; PMID: 15994776
   PubMed Web of Science ®Google Scholar
• Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, Zhou T, Schmidt SD, Wu L, Xu L, et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010; 329:856 - 61; http://dx.doi.org/10.1126/science.1187659; PMID: 20616233
   PubMed Web of Science ®Google Scholar
• Orcutt KD, Ackerman ME, Cieslewicz M, Quiroz E, Slusarczyk AL, Frangioni JV, Wittrup KD. A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel 2010; 23:221 - 8; http://dx.doi.org/10.1093/protein/gzp077; PMID: 20019028
   PubMed Web of Science ®Google Scholar
• Feng Y, Gong R, Dimitrov DS. Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor. Protein Expr Purif 2011; 79:66 - 71; http://dx.doi.org/10.1016/j.pep.2011.03.012; PMID: 21453773
   PubMed Web of Science ®Google Scholar
• Brown EP, Licht AF, Dugast AS, Choi I, Bailey-Kellogg C, Alter G, Ackerman ME. High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. J Immunol Methods 2012; 386:117 - 23; http://dx.doi.org/10.1016/j.jim.2012.09.007; PMID: 23023091
   PubMed Web of Science ®Google Scholar